The aryl hydrocarbon receptor in the crossroad of signalling networks with therapeutic value

ÁC Roman, JM Carvajal-Gonzalez, JM Merino… - Pharmacology & …, 2018 - Elsevier
The aryl hydrocarbon receptor (AhR) is well-known for its major contributions to the cellular
responses against environmental toxins and carcinogens. Notably, AhR has also emerged …

[HTML][HTML] Genetic susceptibility in childhood acute leukaemias: a systematic review

GD Brisson, LR Alves… - …, 2015 - ncbi.nlm.nih.gov
Acute leukaemias (AL) correspond to 25–35% of all cancer cases in children. The aetiology
is still sheltered, although several factors are implicated in causality of AL subtypes …

Multivariate analysis of dopaminergic gene variants as risk factors of heroin dependence

A Vereczkei, Z Demetrovics, A Szekely, P Sarkozy… - PLoS …, 2013 - journals.plos.org
Background Heroin dependence is a debilitating psychiatric disorder with complex
inheritance. Since the dopaminergic system has a key role in rewarding mechanism of the …

Pharmacogenetic analysis of high-dose methotrexate treatment in children with osteosarcoma

M Hegyi, A Arany, AF Semsei, K Csordas, O Eipel… - …, 2016 - pmc.ncbi.nlm.nih.gov
Inter-individual differences in toxic symptoms and pharmacokinetics of high-dose
methotrexate (MTX) treatment may be caused by genetic variants in the MTX pathway …

Is there etiologic heterogeneity between subtypes of childhood acute lymphoblastic leukemia? A review of variation in risk by subtype

LA Williams, JJ Yang, BA Hirsch, EL Marcotte… - … Biomarkers & Prevention, 2019 - AACR
Although substantial advances in the identification of cytogenomic subtypes of childhood
acute lymphoblastic leukemia (ALL) have been made in recent decades, epidemiologic …

Genetic susceptibility in childhood acute lymphoblastic leukemia

A Gutierrez-Camino, I Martin-Guerrero, A García-Orad - Medical Oncology, 2017 - Springer
Acute lymphoblastic leukemia (ALL) is the most common childhood malignancy and a
leading cause of death due to disease in children. The genetic basis of ALL susceptibility …

The role of ARID5B in acute lymphoblastic leukemia and beyond

P Wang, Y Deng, X Yan, J Zhu, Y Yin, Y Shu… - Frontiers in …, 2020 - frontiersin.org
Acute lymphoblastic leukemia (ALL) is the most common malignancy in children with distinct
characteristics among different subtypes. Although the etiology of ALL has not been fully …

[HTML][HTML] HLA-DRB1* 07: 01–HLA-DQA1* 02: 01–HLA-DQB1* 02: 02 haplotype is associated with a high risk of asparaginase hypersensitivity in acute lymphoblastic …

N Kutszegi, X Yang, A Gézsi, G Schermann… - …, 2017 - ncbi.nlm.nih.gov
Hypersensitivity reactions are the most frequent dose-limiting adverse reactions to
Escherichia coli-derived asparaginase in pediatric acute lymphoblastic leukemia (ALL) …

Roles of genetic polymorphisms in the folate pathway in childhood acute lymphoblastic leukemia evaluated by Bayesian relevance and effect size analysis

O Lautner-Csorba, A Gezsi, DJ Erdelyi, G Hullam… - PloS one, 2013 - journals.plos.org
In this study we investigated whether polymorphisms in the folate pathway influenced the
risk of childhood acute lymphoblastic leukemia (ALL) or the survival rate of the patients. For …

Associations of novel genetic variations in the folate‐related and ARID5B genes with the pharmacokinetics and toxicity of high‐dose methotrexate in paediatric acute …

K Csordas, O Lautner‐Csorba… - British journal of …, 2014 - Wiley Online Library
High‐dose methotrexate (HD‐MTX) plays an important role in the consolidation therapy of
acute lymphoblastic leukaemia (ALL) in many treatment regimens worldwide. However …